De Novo

/De Novo

Medicines for Parkinson’s Disease

2018-03-21T18:40:16+00:00By |Categories: De Novo, Established Treatments|

The major classes of anti-Parkinson medication include carbidopa-levodopa (often referred to as Sinemet), catechol-o-methyltransferase inhibitors or COMT inhibitors, monoamine oxidase type B inhibitors, dopamine agonists, amantadine, and anticholinergics. Many of these medications are used in combinations although some of these may be used by themselves (in monotherapy) for treatment of symptoms of Parkinson’s disease. Levodopa [...]

Exercise, Diet, and Therapy for Parkinson’s Disease

2018-03-21T19:15:31+00:00By |Categories: De Novo, Established Treatments, Intermediate & Advanced PD|

Exercise has shown to be helpful for maintenance of good health for normal individuals in the population. It has especially been demonstrated to improve a variety of different features of Parkinson’s disease including gait, strength, balance, and speed of movement. In the general population including patients with Parkinson’s disease, cardiovascular exercise improves cognitive function, mood, [...]

Non-Motor Symptoms of Parkinson’s Disease

2018-03-21T18:39:07+00:00By |Categories: About Parkinson's Disease, De Novo|

Often non-motor symptoms of Parkinson’s Disease can be overlooked and thought to be unassociated with PD, especially in the early stages of the disease. However, there are a variety of non-motor symptoms that can affect up to 50% of the PD population. Two of the major non-motor symptoms include cognitive changes and mood disorders. Cognitive [...]